Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Patients can also check whether products have been authorized for sale by searching Health Canada's Drug Product Database and Licensed Natural Health Product Database
The strongest suppliers are building around familiar formats instead of trying to invent a completely new eating occasion
Much like returning to physical activity postpartum, its best to give your body time to rest and heal after giving birth
The difference between REPATHA and placebo in mean percent change in LDL-C from baseline to Week 12 was 31% (95% CI: 44%, 18%
The three-phase constipation pattern: acute, adaptation, and resolution Based on patterns across published trials and clinical observation, GLP-1 constipation follows a predictable three-phase trajectory in most patients: Phase 1: Acute onset (weeks 1-4) Constipation begins 7-14 days after starting Ozempic or escalating dose Bowel movement frequency drops from baseline (e.g., daily to every 2-3 days) Stool becomes harder and requires more straining Bloating and abdominal fullness are common Patients often mistake this for "the medication working" because fullness overlaps with satiety Phase 2: Adaptation (weeks 4-12) The colon begins compensating for slowed GLP-1-mediated motility Bowel movement frequency stabilizes (not back to baseline but consistent) Stool consistency improves slightly Symptoms plateau rather than worsen Patients who add fiber or osmotic laxatives during this phase see the most benefit Phase 3: Resolution or persistence (week 12+) 60-70% of patients return to near-baseline bowel habits 15-20% have mild persistent constipation that's manageable with dietary changes 10-15% have moderate to severe persistent constipation requiring ongoing laxative use A small subset (2-3%) cannot tolerate the constipation and discontinue treatment The key clinical decision point is week 12
